Navigation Links
National Patient Advocate Foundation Urges Ohio Legislature to Support Oral Chemotherapy Legislation
Date:11/14/2012

COLUMBUS, Ohio, Nov. 14, 2012 /PRNewswire-USNewswire/ -- The National Patient Advocate Foundation (NPAF) voiced strong support for the Oral Chemotherapy Legislation (SB194) at a hearing before the Senate, Commerce and Labor Committee yesterday.  The bill ensures equity for patient out-of-pocket costs for oral and intravenous (IV) chemotherapy anti-cancer medications and protects patients by ensuring they receive their IV chemotherapy in a safe manner.

While chemotherapy has traditionally been provided through intravenous treatments, new cancer care medications are available that allow patients to administer them orally, improving patient quality of life and reducing avoidable hospital visits.  Unfortunately, these new medications often come at an extremely high cost to the patient, limiting patient access and burdening patients will financially-crippling expenses that are not currently covered under insurance plan prescription drug benefits.

Kathleen Werling, a two-time cancer survivor currently undergoing treatment for Stage IV Malignant Melanoma, spoke at yesterday's hearing in support of the legislation based on her personal experiences with high out-of-pocket costs for her IV treatment that devastated her family financially.  "We had already incurred hundreds of thousands of dollars in medical debt from the first diagnosis of my Melanoma due to it being a pre-existing condition. We had drained our college funds of six children, along with our retirement fund.  We were living day to day, paycheck to paycheck," Werling stated. "So you can understand our devastation."

NPAF strongly believes that all anti-cancer medications should be offered to patients at equitable prices.  In a letter to the Committee Chairman Kevin Bacon, NPAF states, "SB194 would make it easier for patients to afford oral and anti-cancer medications, and would also provide patients across Ohio with a higher quality of life.  For these reasons, the National Patient Advocate Foundation is pleased to support this bill."

"I see firsthand the impact and struggle patients face when they are making decisions about whether or not they can afford their medications," stated Lisa Miller, a patient advocate at a large cancer center in central Ohio and NPAF Elite Council volunteer. "Imagine how hard it would be knowing you could be one or two treatments away from a cure and not have the ability to obtain the treatment because it is not covered or the out-of-pocket expense is astronomical."

Added Miller, "I am asking you on behalf of all constituents in Ohio to pass this bill and give patients the affordable option for oral anti-cancer medications.  It's the right thing to do."


'/>"/>
SOURCE National Patient Advocate Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
6. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
9. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
10. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... , February 9, 2016 ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QGEN ... collaboration with 10x Genomics to develop and promote ... and bioinformatics. --> QIAGEN N.V. (NASDAQ: ...
(Date:2/9/2016)... 9, 2016 Mast Therapeutics, Inc. (NYSE ... sickle cell disease and heart failure, today announced that it ... purchase common stock in an underwritten public offering.  The offering ... be no assurance as to whether or when the offering ... terms of the offering.   --> ...
(Date:2/9/2016)... FRANCISCO , February 9, 2016 ... biotechnology company focused on developing products for Regenerative Medicine, ... be a featured presenting company at Source Capital Group,s ... on February 10-11, 2016 in New York ... on Wednesday, February 10, 2016 at 12:30 pm by ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit ... as the latest addition to its growing list of Partner Firms. S.S. ... Southeast, from Orlando to Huntsville and in between. , Harnessing the experience and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: ... winner and inspirational speaker Jan Fox will serve as keynote speaker at the ... provide participants with tools to more effectively communicate with their own organizational staff ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... it has been awarded the prestigious Distinguished Emerald Club of the World award, ... by BoardRoom magazine, one of the most respected trade publications serving private clubs. ...
(Date:2/10/2016)... Petaluma, CA (PRWEB) , ... February 10, 2016 , ... ... newest and most versatile series of monitor mounts ever. , “Our goal was ... flexible and easy to install system that we have ever created.” said Darren Hulsey, ...
(Date:2/10/2016)... ... February 09, 2016 , ... A new leadership team for Mid-South ... President Joe Wiley made the announcement Monday night, Feb. 8, prior to the evening ... of FHU and the creator of GO! Camp, has been named director. Gayle McDonald, ...
Breaking Medicine News(10 mins):